50 citations
,
May 1999 in “Journal of Reconstructive Microsurgery”
This study concluded that microsurgical reconstruction is a reliable method to achieve stable coverage of large, complex scalpdefects, although cancer control rates were poor.
10 citations
,
May 2009 in “Journal of The American Academy of Dermatology”
This case report describes a dual transposition flap technique for closing large scalpdefects post-Mohs surgery, achieving minimal alopecia and scar visibility, though it is based on a single patient.
7 citations
,
March 2017 in “Annals of Plastic Surgery”
In this study, researchers developed a new variant of the Mercedes flap with releasing incisions for reconstructing medium-sized scalpdefects, demonstrating complete defect closure without complications in three patients following a single operation with excellent aesthetic outcomes.
1 citations
,
August 2023 in “International Journal of Surgery Case Reports”
In this study, free flaps, specifically the ALT-free tissue transfer, were found to be safe and reliable for reconstructing large scalpdefects requiring both scalp and skull repairs, with consistent results observed in clinical applications.
Ultrasound imaging can non-invasively detect active and inactive hair follicles, inflammation, and fibrosis, potentially reducing unnecessary biopsies. It may help assess hair growth potential and diagnose scalp issues, but some users believe in trying treatments regardless of ultrasound results.
The conversation discusses starting finasteride for hair loss, with the original poster noting reduced scalp itching and oiliness after the first week. Users share experiences with different dosages and schedules, concerns about side effects, and the potential impact on prostate cancer detection.
Reducing DHT in the scalp is ideal for hair retention, with topical finasteride and dutasteride being common treatments. Some users report side effects like reduced libido, while others experiment with higher doses for regrowth.
A company is developing a topical dutasteride that targets hair follicles without significantly affecting systemic DHT levels, with trials underway to measure its effectiveness. Users discuss the potential benefits and skepticism around the formulation compared to existing treatments.
The user is experiencing progressive hair thinning despite using finasteride and dutasteride. A biopsy confirmed male pattern baldness, and minoxidil was suggested as an additional treatment.